Back to Journals » Drug Design, Development and Therapy » Volume 11

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines

Total article views   Abstract views HTML views PDF downloads Totals
8,833 Dovepress* 7,340 803+ 1,299 8,143
PubMed Central* 0 690 272 690
Totals 7,340 1,493 1,571 8,833
*Since 3 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 2 3

View citations on PubMed Central and Google Scholar